Name: GSM2212077 - Doxorubicin5 vs Control5, 4 week post treatment, reverse labelling
Creator: Saket Lab
License: https://www.ncbi.nlm.nih.gov/geo/info/disclaimer.html

GSM2212077 - Doxorubicin5 vs Control5, 4 week post treatment, reverse labelling | seqout